2011 Focused update of 2009 American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer

Journal of Oncology Practice

Volumn 8, Issue 1, 2012, Pages 63-66

  Azzoli, Christopher G ^a,b,c   Temin, Sarah ^a,b,c   Giaccone, Giuseppe ^a,b,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b AMERICAN SOCIETY OF CLINICAL ONCOLOGY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; ERLOTINIB; GEFITINIB; IRINOTECAN; NAVELBINE; PACLITAXEL; PEMETREXED;

CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL PRACTICE; CLINICAL TRIAL; HUMAN; LUNG NON SMALL CELL CANCER; MAINTENANCE THERAPY; MEDICAL SOCIETY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; PRACTICE GUIDELINE; REVIEW; THROMBOCYTOPENIA;

EID: 84863088941     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2011.000374     Document Type: Review

References (2)

1. Azzoli CG, Baker S Jr, Temin S, et al: American Society of Clinical Oncology Clinical Practice Guideline Update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol 27:6251-6266, 2009
2. Azzoli CG, Temin S, Aliff T, et al: 2011 focused update of American Society of Clinical Oncology Clinical Practice Guideline Update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol 29:3825-3831, 2011